Intra-Cellular Therapies, Inc.
Pharmaceutical capsule compositions comprising lumateperone mono-tosylate

Last updated:

Abstract:

The present disclosure relates to pharmaceutical capsules comprising lumateperone, in free, or pharmaceutically acceptable salt form, optionally in combination with one or more additional therapeutic agents, processes for manufacture thereof and methods of use in the treatment or prophylaxis of disease.

Status:
Grant
Type:

Utility

Filling date:

30 Aug 2019

Issue date:

30 Jun 2020